LCN2 and infection: In both infection scenarios, S100a8-supplemented MN mice showed less intestinal and also less systemic inflammation as measured by restricted increases of Lcn-2 levels in the stool and blood upon infection compared to untreated MN pups (Figs. 5b, g).